Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response.
about
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer VaccinesStrategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen ModificationMUC1 glycopeptide epitopes predicted by computational glycomics.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Synthesis of homogeneous MUC1 oligomers via a bi-directional ligation strategy.Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4'-deoxy-4'-fluoro-Thomsen-Friedenreich epitope.Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions.Multivalent glyco(cyclo)peptides.Be squared: expanding the horizon of squaric acid-mediated conjugations.Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines.Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.Recent progress in antitumoral synthetic vaccines.Self-Assembled Nano-Immunostimulant for Synergistic Immune Activation.Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models.Convergent synthesis of MUC1 glycopeptides via serine ligation.Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides.
P2860
Q26740513-FC84E5BF-B30B-4AC4-8C9F-D39C2061276DQ27001592-26F8794E-7336-470E-BA41-E44EE8AC4595Q34424743-28C2E9DF-F925-4DBF-A128-167E6933F692Q34489424-A294BB2E-CDEF-45D6-91D8-033451216E34Q34901076-65A364C7-AB96-40F0-A459-C971BB95672DQ35030845-008E4C20-014E-4967-8C52-677F85BB96FCQ35904166-8BE51E40-03E2-4C2B-B773-6DFAA4671567Q37581781-30E7DBF2-3C4B-4FDA-8B3E-EB4FE7CCC502Q38069441-06523CCE-70BE-455B-B5A4-36F9676A1474Q38123105-597BF57A-73C7-4960-A123-3FD835C1E39EQ38962995-F192CE51-595C-4853-AEEA-22669F28C50AQ39169715-B5E6B7C5-C101-44FD-81EC-48BC5A97B6BFQ39254744-5BA80968-26DC-4149-8886-7CF5298A56E9Q43007810-EF0CE6BF-AB76-4466-A184-754A180F57B3Q48761437-916C0B0A-F695-41A0-A6A5-21EDEA93C337Q50234200-FBF9C895-CB57-45B7-AD61-5DB651EDF76EQ50940828-5EA9A787-03CB-4C3A-84C1-4311DF6CC828Q53093803-E234FEEA-730F-4D7E-86CB-A81E11FD5CEC
P2860
Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Variation of the glycosylation ...... luence on the immune response.
@en
Variation of the glycosylation ...... luence on the immune response.
@nl
type
label
Variation of the glycosylation ...... luence on the immune response.
@en
Variation of the glycosylation ...... luence on the immune response.
@nl
prefLabel
Variation of the glycosylation ...... luence on the immune response.
@en
Variation of the glycosylation ...... luence on the immune response.
@nl
P2093
P2860
P356
P1476
Variation of the glycosylation ...... luence on the immune response.
@en
P2093
Horst Kunz
Yan-Mei Li
Yu-Fen Zhao
Zhan-Yi Sun
Zhi-Hua Huang
P2860
P304
P356
10.1002/ANIE.201106396
P407
P577
2012-01-13T00:00:00Z